News
6d
News-Medical.Net on MSNScientists use AI to build mutation-proof antibodies for SARS-CoV-2Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron.
8h
News-Medical.Net on MSNNew AI tool predicts viral mutations to help future-proof COVID vaccinesA novel AI-driven method helps scientists stay ahead of viral evolution by engineering synthetic spike proteins that ...
At the intersection of radiation and precision, Novartis, Bayer, AstraZeneca and more hope to cash in on a ...
6d
India Today on MSNThis man was bitten by snakes 200 times. What his blood can do now is incredibleScientists took blood from Tim Friede, who, according to his online biography, began self-administering diluted venom as a ...
6d
Clinical Trials Arena on MSNFDA clears OBI Pharma’s IND to begin Phase I/II solid tumour trialOBI Pharma has received clearance from the US FDA for an IND application for OBI-902 to begin a Phase I/II trial for advanced ...
If you've been hopping between arms for booster shots, a new study suggests that your lymph nodes remember exactly where you ...
Tuberculosis, the world's deadliest infectious disease, is estimated to infect around 10 million people each year, and kills ...
Cryptic peptides, which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, according to a new study.
As part of our efforts to demonstrate the applicability of AJICAP®, we have been advancing joint research with RIBOMIC ...
Your friends might be your underrated health supplement highlights how connection affects immunity, stress, sleep, and ...
Blood type’s influence extends far beyond compatibility for blood donations, affecting the body through multiple biological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results